TAMIFLU Side Effects

6826813-4 | Shock, Toxic Skin Eruption
on Jun 29, 2010 Female patient from JAPAN , weighting 132.3 lb, was diagnosed with influenza and was treated with Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: shock, toxic skin eruption. Tamiflu dosage: . During the same period patient was treated with CALONAL (Form: Peroral Agent. Note: 400mg X 2-3 Times/day.) (View Calonal Review and Calonal Label ), MAO TO (Granulated Powder) (View Mao-to Review and Mao-to Label ). Patient was hospitalized.

6826806-7 | Abortion Spontaneous, Foetal Malformation
Patient was taking Tamiflu (View Usage). Patient had the following side effects: abortion spontaneous, foetal malformation on Jul 01, 2010 from BRAZIL Additional patient health information: Female patient , weighting 163.1 lb, . Tamiflu dosage: .

6819958-6 | Interstitial Lung Disease
Adverse event was reported on Jun 23, 2010 by a Female patient taking Tamiflu (View Usage) (Dosage: ) . Location: JAPAN , 53 years of age, After Tamiflu was administered, patient had the following side effects: interstitial lung disease.

6819939-2 | Overdose, Renal Failure Acute, Sepsis, Urinary Tract Infection
on Jun 28, 2010 Female patient from JAPAN , 57 years of age, weighting 130.1 lb, was treated with Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: overdose, renal failure acute, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?). Tamiflu dosage: . During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MICARDIS (View Micardis Review and Micardis Label ), BASEN (View Basen Review and Basen Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.


6819933-1 |
on Jun 25, 2010 Female patient from INDIA , 58 years of age, was treated with Tamiflu (View Usage). . Tamiflu dosage: .

6819897-0 | Aspergillosis, Haemodynamic Instability, Ileus Paralytic, Pathogen Resistance, Renal Failure, Thrombocytopenia
Patient was taking Tamiflu (View Usage). After Tamiflu was administered, patient had the following side effects: aspergillosis, haemodynamic instability, ileus paralytic, pathogen resistance, renal failure, thrombocytopenia on Jun 23, 2010 from NETHERLANDS Additional patient health information: Male patient , 58 years of age, was diagnosed with h1n1 influenza and. Tamiflu dosage: For 5 Days. During the same period patient was treated with ZANAMIVIR (Oral Inhalation) (View Zanamivir Review and Zanamivir Label ).

6812681-3 | Acute Respiratory Failure, Haemorrhage
Adverse event was reported on Jun 23, 2010 by a Female patient taking Tamiflu (View Usage) (Dosage: ) was diagnosed with h1n1 influenza and. Location: BRAZIL , 35 years of age, Patient experienced the following unwanted or unexpected effects: acute respiratory failure, haemorrhage.

6804893-X | Overdose, Renal Failure Acute, Sepsis
on Jun 16, 2010 Female patient from JAPAN , 57 years of age, was treated with Tamiflu (View Usage). Patient had the following side effects: overdose, renal failure acute, sepsis (What is sepsis?). Tamiflu dosage: . Patient was hospitalized.

6801472-5 |
on Jun 22, 2010 Male patient from INDIA , child 1 years of age, was diagnosed with h1n1 influenza and was treated with Tamiflu (View Usage). . Tamiflu dosage: .

6795068-1 | Liver Disorder
Patient was taking Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Jun 16, 2010 from JAPAN Additional patient health information: Male patient , 74 years of age, . Tamiflu dosage: . Patient was hospitalized.

6790531-1 | Cough, Dyspnoea, Immunodeficiency, Oropharyngeal Pain, Pyrexia, Rhinitis
Adverse event was reported on Jun 16, 2010 by a Female patient taking Tamiflu (View Usage) (Dosage: ) was diagnosed with h1n1 influenza and. Location: BRAZIL , 43 years of age, Patient had the following side effects: cough, dyspnoea, immunodeficiency, oropharyngeal pain, pyrexia, rhinitis.

6790425-1 | Encephalopathy
on Jun 16, 2010 Male patient from JAPAN , child 5 years of age, was diagnosed with influenza and was treated with Tamiflu (View Usage). After Tamiflu was administered, patient had the following side effects: encephalopathy. Tamiflu dosage: .

6786284-3 | Cardiac Failure, Dyspnoea, Myocardial Infarction, Vomiting
on Jun 15, 2010 Female patient from UNITED KINGDOM , 46 years of age, was treated with Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, dyspnoea, myocardial infarction, vomiting. Tamiflu dosage: .

6786250-8 | Cardio-respiratory Arrest, Coma, Cough
Patient was taking Tamiflu (View Usage). Patient had the following side effects: cardio-respiratory arrest, coma, cough on Jun 16, 2010 from BRAZIL Additional patient health information: Female patient , 30 years of age, was diagnosed with h1n1 influenza and. Tamiflu dosage: .

6783617-9 | Encephalopathy
Adverse event was reported on Jun 14, 2010 by a Female patient taking Tamiflu (View Usage) (Dosage: ) . Location: JAPAN , 16 years of age, After Tamiflu was administered, patient had the following side effects: encephalopathy. Patient was hospitalized.

6781520-1 | Abnormal Behaviour
on Jun 14, 2010 Male patient from JAPAN , weighting 55.12 lb, was diagnosed with influenza and was treated with Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour. Tamiflu dosage: . During the same period patient was treated with BISOLVON (View Bisolvon Review and Bisolvon Label ), MUCODYNE (Dose Form: Minute Grain) (View Mucodyne Review and Mucodyne Label ), MEPTIN (View Meptin Review and Meptin Label ). Patient was hospitalized.

6779257-8 | H1n1 Influenza
on Jun 10, 2010 Female patient from BRAZIL , 32 years of age, was diagnosed with h1n1 influenza and was treated with Tamiflu (View Usage). Patient had the following side effects: h1n1 influenza. Tamiflu dosage: .

6774715-4 | Foetal Growth Retardation
Patient was taking Tamiflu (View Usage). After Tamiflu was administered, patient had the following side effects: foetal growth retardation on Jun 09, 2010 from FRANCE Additional patient health information: Male patient , weighting 5.29 lb, . Tamiflu dosage: . During the same period patient was treated with DOLIPRANE (View Doliprane Review and Doliprane Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ), FORLAX (View Forlax Review and Forlax Label ).

6774638-0 | Pneumonia Staphylococcal
Adverse event was reported on Jun 05, 2010 by a Male patient taking Tamiflu (View Usage) (Dosage: ) was diagnosed with influenza and. Location: UNITED STATES , weighting 160.9 lb, Patient experienced the following unwanted or unexpected effects: pneumonia staphylococcal. During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), ROBITUSSIN DM (View Robitussin Dm Review and Robitussin Dm Label ). Patient was hospitalized.

6771511-9 | Dandy-walker Syndrome, Pierre Robin Syndrome
on Jun 08, 2010 Female patient from JAPAN , weighting 5.07 lb, was treated with Tamiflu (View Usage). Patient had the following side effects: dandy-walker syndrome, pierre robin syndrome. Tamiflu dosage: .

6767822-3 | Cholelithiasis, Cholestasis, Cytolytic Hepatitis
on Jun 09, 2010 Male patient from FRANCE , 33 years of age, was diagnosed with h1n1 influenza and was treated with Tamiflu (View Usage). After Tamiflu was administered, patient had the following side effects: cholelithiasis, cholestasis, cytolytic hepatitis. Tamiflu dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), TAVANIC (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

6765783-4 | Dizziness, Dyspnoea, Memory Impairment, Nausea
Patient was taking Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dyspnoea, memory impairment, nausea (What is nausea?) on Jun 03, 2010 from JAPAN Additional patient health information: Female patient , 83 years of age, weighting 119.0 lb, . Tamiflu dosage: . During the same period patient was treated with SELBEX (View Selbex Review and Selbex Label ), ZADITEN (Route: Nasal) (View Zaditen Review and Zaditen Label ), SOLDEM (View Soldem Review and Soldem Label ).

6763745-4 | Abdominal Pain, Diarrhoea, Hyperglycaemia, Nausea, Renal Failure Acute
Adverse event was reported on Jun 01, 2010 by a Male patient taking Tamiflu (View Usage) (Dosage: ) was diagnosed with influenza and. Location: JAPAN , 50 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, hyperglycaemia, nausea (What is nausea?), renal failure acute.

6761438-0 |
on Jun 01, 2010 Female patient from BRAZIL , 43 years of age, was diagnosed with h1n1 influenza and was treated with Tamiflu (View Usage). . Tamiflu dosage: .

6757131-0 | Pathogen Resistance
on May 25, 2010 Male patient from NETHERLANDS , 58 years of age, was diagnosed with h1n1 influenza and was treated with Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: pathogen resistance. Tamiflu dosage: . During the same period patient was treated with ZANAMIVIR (View Zanamivir Review and Zanamivir Label ).

6756276-9 | Stillbirth
Patient was taking Tamiflu (View Usage). Patient had the following side effects: stillbirth on May 25, 2010 from NORWAY Additional patient health information: Male patient , weighting 1.76 lb, . Tamiflu dosage: Dosage Regimen Reported As 1+1.. During the same period patient was treated with PANDEMRIX (Dose Reported As Dose Form. Dosage Regimen Reported As 1.) (View Pandemrix Review and Pandemrix Label ).

6753686-0 | Aplastic Anaemia
Adverse event was reported on May 28, 2010 by a Female patient taking Tamiflu (View Usage) (Dosage: ) was diagnosed with influenza, depression (What is depression?) and. Location: GERMANY , 39 years of age, After Tamiflu was administered, patient had the following side effects: aplastic anaemia. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), AVELOX (View Avelox Review and Avelox Label ), RANITIDINA (View Ranitidina Review and Ranitidina Label ), 5 HTP (View 5-htp Review and 5-htp Label ). Patient was hospitalized.

6752615-3 | Coagulopathy, Hepatic Failure, Hypotension, Pancreatitis Acute, Renal Failure Acute, Stevens-johnson Syndrome, Tachycardia, Tachypnoea, Toxic Epidermal Necrolysis
on Jun 01, 2010 Female patient from UNITED STATES , 57 years of age, weighting 111.0 lb, was diagnosed with influenza, ear pain, pyrexia and was treated with Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: coagulopathy, hepatic failure, hypotension, pancreatitis acute, renal failure acute, stevens-johnson syndrome, tachycardia, tachypnoea, toxic epidermal necrolysis. Tamiflu dosage: 75 Mg Twice Daily Po. During the same period patient was treated with IBUPROFEN (200-400 Mg Every 4-6 Hours Po) (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized and became disabled.

6751535-8 | Chest Pain, Coma, Cough, Dyspnoea, Pyrexia
on May 24, 2010 Female patient from BRAZIL , 30 years of age, was diagnosed with h1n1 influenza and was treated with Tamiflu (View Usage). Patient had the following side effects: chest pain (What is chest pain?), coma, cough, dyspnoea, pyrexia. Tamiflu dosage: .

6749325-5 | Abnormal Behaviour
Patient was taking Tamiflu (View Usage). After Tamiflu was administered, patient had the following side effects: abnormal behaviour on May 18, 2010 from JAPAN Additional patient health information: Male patient , weighting 55.12 lb, was diagnosed with influenza and. Tamiflu dosage: . During the same period patient was treated with BISOLVON (View Bisolvon Review and Bisolvon Label ), MUCODYNE (Dose Form: Minute Grain) (View Mucodyne Review and Mucodyne Label ), MEPTIN (View Meptin Review and Meptin Label ). Patient was hospitalized.

6746378-5 | Altered State Of Consciousness, Haemodialysis, Overdose, Pneumococcal Sepsis, Pneumonia Pneumococcal, Renal Failure Acute, Respiratory Failure, Rhabdomyolysis
Adverse event was reported on May 19, 2010 by a Male patient taking Tamiflu (View Usage) (Dosage: ) . Location: JAPAN , 57 years of age, weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: altered state of consciousness, haemodialysis, overdose, pneumococcal sepsis, pneumonia pneumococcal, renal failure acute, respiratory failure, rhabdomyolysis. Patient was hospitalized.

6739664-6 | Aplastic Anaemia
on May 13, 2010 Female patient from GERMANY , 39 years of age, was diagnosed with influenza, depression (What is depression?) and was treated with Tamiflu (View Usage). Patient had the following side effects: aplastic anaemia. Tamiflu dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), AVELOX (View Avelox Review and Avelox Label ), RANITIDINA (View Ranitidina Review and Ranitidina Label ), 5 HTP (View 5-htp Review and 5-htp Label ). Patient was hospitalized.

6739650-6 | Tachycardia, Urticaria
on Apr 06, 2010 Male patient from FRANCE , 58 years of age, was treated with Tamiflu (View Usage). After Tamiflu was administered, patient had the following side effects: tachycardia, urticaria. Tamiflu dosage: . During the same period patient was treated with PYOSTACINE (View Pyostacine Review and Pyostacine Label ), PANDEMRIX (Form: Injection) (View Pandemrix Review and Pandemrix Label ). Patient was hospitalized.

6737986-6 | Acute Respiratory Failure, Hypertension, Pneumonitis, Urinary Tract Infection
Patient was taking Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, hypertension, pneumonitis, urinary tract infection (What is urinary tract infection?) on May 14, 2010 from BRAZIL Additional patient health information: Female patient , 22 years of age, was diagnosed with h1n1 influenza and. Tamiflu dosage: . During the same period patient was treated with INFLUENZA VIRUS VACCINE (View Influenza Virus Vaccine Review and Influenza Virus Vaccine Label ).

6737977-5 | Abortion Induced
Adverse event was reported on May 14, 2010 by a Female patient taking Tamiflu (View Usage) (Dosage: Note: 2-3 Days Taking.) was diagnosed with influenza and. Location: JAPAN , weighting 105.8 lb, Patient had the following side effects: abortion induced.

6737965-9 | Hypophagia, Incorrect Dose Administered, Insomnia, Oral Infection, Pyrexia, Rash, Vomiting
on May 19, 2010 Male patient from UNITED KINGDOM , child 1 years of age, was treated with Tamiflu (View Usage). After Tamiflu was administered, patient had the following side effects: hypophagia, incorrect dose administered, insomnia, oral infection, pyrexia, rash (What is rash?), vomiting. Tamiflu dosage: .

6736150-4 |
on May 13, 2010 Female patient from NETHERLANDS , weighting 160.9 lb, was treated with Tamiflu (View Usage). . Tamiflu dosage: Route: Per Os. During the same period patient was treated with MESALAZINE (Started Prior To Pregnancy) (View Mesalazine Review and Mesalazine Label ).

6736131-0 | Frequent Bowel Movements, Jaundice, Weight Decreased
Patient was taking Tamiflu (View Usage). Patient had the following side effects: frequent bowel movements, jaundice (What is jaundice?), weight decreased on May 17, 2010 from FRANCE Additional patient health information: Male patient , weighting 7.50 lb, . Tamiflu dosage: . Patient was hospitalized.

6733930-6 | Dyspnoea
Adverse event was reported on May 05, 2010 by a Female patient taking Tamiflu (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 119.0 lb, After Tamiflu was administered, patient had the following side effects: dyspnoea. During the same period patient was treated with ALBUTEROL (Unk) (View Albuterol Review and Albuterol Label ), RACEMIC EPINEPHRINE (View Racemic Epinephrine Review and Racemic Epinephrine Label ), ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), THEOPHYLLINE (200 Mg, Bid) (View Theophylline Review and Theophylline Label ), SINGULAIR (10 Mg, Qhs) (View Singulair Review and Singulair Label ). Patient was hospitalized.

6733906-9 | Abnormal Behaviour
on May 11, 2010 Male patient from JAPAN , 35 years of age, was diagnosed with influenza and was treated with Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour. Tamiflu dosage: .

6731136-8 | Abnormal Behaviour
on Feb 08, 2010 Female patient from JAPAN , weighting 57.32 lb, was treated with Tamiflu (View Usage). Patient had the following side effects: abnormal behaviour. Tamiflu dosage: . During the same period patient was treated with MEIACT (View Meiact Review and Meiact Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), HUSCODE (View Huscode Review and Huscode Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), CALONAL (View Calonal Review and Calonal Label ).

6727797-X | Delirium, Hallucination, Auditory
Patient was taking Tamiflu (View Usage). After Tamiflu was administered, patient had the following side effects: delirium, hallucination, auditory on May 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , child 7 years of age, . Tamiflu dosage: Active Constituent: Oseltamivir Phosphate, Dose And Frequency: Not Reported..

6725662-5 | Abnormal Behaviour
Adverse event was reported on May 06, 2010 by a Male patient taking Tamiflu (View Usage) (Dosage: ) was diagnosed with influenza and. Location: JAPAN , 35 years of age, Patient experienced the following unwanted or unexpected effects: abnormal behaviour.

6725636-4 | Intrapartum Haemorrhage, Uterine Atony
on May 06, 2010 Female patient from SWITZERLAND , 21 years of age, was treated with Tamiflu (View Usage). Patient had the following side effects: intrapartum haemorrhage, uterine atony. Tamiflu dosage: .

6725630-3 | Agitation, Irritability
on May 04, 2010 Male patient from SWITZERLAND , child 5 years of age, was diagnosed with h1n1 influenza and was treated with Tamiflu (View Usage). After Tamiflu was administered, patient had the following side effects: agitation, irritability. Tamiflu dosage: . During the same period patient was treated with PARACETAMOL (Short Term Use) (View Paracetamol Review and Paracetamol Label ).

6724290-5 | Intrapartum Haemorrhage
Patient was taking Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: intrapartum haemorrhage on May 06, 2010 from SWITZERLAND Additional patient health information: Female patient , 28 years of age, . Tamiflu dosage: .

6724288-7 | Cytolytic Hepatitis, Hepatic Failure, Renal Failure
Adverse event was reported on May 06, 2010 by a Female patient taking Tamiflu (View Usage) (Dosage: ) . Location: FRANCE , weighting 21.16 lb, Patient had the following side effects: cytolytic hepatitis, hepatic failure, renal failure. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), ASPEGIC 1000 (Dose: 100) (View Aspegic 1000 Review and Aspegic 1000 Label ), PERFALGAN (150 Every 6 Hours) (View Perfalgan Review and Perfalgan Label ), VALIUM (View Valium Review and Valium Label ), GARDENAL (View Gardenal Review and Gardenal Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6724134-1 | No Adverse Event
on Feb 04, 2010 Female patient from JAPAN , 29 years of age, was diagnosed with antiviral prophylaxis and was treated with Tamiflu (View Usage). After Tamiflu was administered, patient had the following side effects: no adverse event. Tamiflu dosage: .

6723969-9 | Influenza, Pathogen Resistance
on Apr 21, 2010 Male patient from UNITED STATES , 51 years of age, was treated with Tamiflu (View Usage). Patient experienced the following unwanted or unexpected effects: influenza, pathogen resistance. Tamiflu dosage: . Patient was hospitalized.

6723868-2 | Cytolytic Hepatitis, Hepatic Failure
Patient was taking Tamiflu (View Usage). Patient had the following side effects: cytolytic hepatitis, hepatic failure on Mar 05, 2010 from FRANCE Additional patient health information: Female patient , weighting 21.16 lb, . Tamiflu dosage: . During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), ASPEGIC 1000 (Dose: 100) (View Aspegic 1000 Review and Aspegic 1000 Label ), PERFALGAN (150 Every 6 Hours) (View Perfalgan Review and Perfalgan Label ), VALIUM (View Valium Review and Valium Label ), GARDENAL (View Gardenal Review and Gardenal Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.